Literature DB >> 12403613

The place of inactivated actin and its kinetic predecessor in actin folding-unfolding.

Irina M Kuznetsova1, Olga V Stepanenko, Olesia V Stepanenko, Olga I Povarova, Alexander G Biktashev, Vladislav V Verkhusha, Mikhail M Shavlovsky, Konstantin K Turoverov.   

Abstract

The kinetics of actin unfolding induced by guanidine hydrochloride of different concentrations was studied. The parametric representation of the kinetic dependencies of tryptophan fluorescence intensity changes recorded at two wavelengths allowed us to detect and characterize a new essentially unfolded kinetic intermediate. Its characteristics suggested that this intermediate state is a premolten globule. It was shown that the equilibrium transition between inactivated and completely unfolded states is also a two-step process and proceeds via an essentially unfolded kinetic intermediate. The new kinetic pathway of actin unfolding--refolding was proposed. According to it, the founded essentially unfolded kinetic state is the on-pathway intermediate, while inactivated actin is the off-pathway misfolded state stabilized by aggregation of partially folded macromolecules of protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403613     DOI: 10.1021/bi026412x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

Review 1.  Development of free-energy-based models for chaperonin containing TCP-1 mediated folding of actin.

Authors:  Gabriel M Altschuler; Keith R Willison
Journal:  J R Soc Interface       Date:  2008-12-06       Impact factor: 4.118

Review 2.  Disordered proteinaceous machines.

Authors:  Monika Fuxreiter; Ágnes Tóth-Petróczy; Daniel A Kraut; Andreas Matouschek; Andreas T Matouschek; Roderick Y H Lim; Bin Xue; Lukasz Kurgan; Vladimir N Uversky
Journal:  Chem Rev       Date:  2014-04-04       Impact factor: 60.622

3.  Distinct effects of guanidine thiocyanate on the structure of superfolder GFP.

Authors:  Olesya V Stepanenko; Olga V Stepanenko; Irina M Kuznetsova; Daria M Shcherbakova; Vladislav V Verkhusha; Konstantin K Turoverov
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

4.  Thermal denaturation and aggregation of myosin subfragment 1 isoforms with different essential light chains.

Authors:  Denis I Markov; Eugene O Zubov; Olga P Nikolaeva; Boris I Kurganov; Dmitrii I Levitsky
Journal:  Int J Mol Sci       Date:  2010-10-27       Impact factor: 5.923

5.  Differences in the pathways of proteins unfolding induced by urea and guanidine hydrochloride: molten globule state and aggregates.

Authors:  Olga I Povarova; Irina M Kuznetsova; Konstantin K Turoverov
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

6.  Determination of LMF binding site on a HSA-PPIX complex in the presence of human holo transferrin from the viewpoint of drug loading on proteins.

Authors:  Zohreh Sattar; Mohammad Reza Saberi; Jamshidkhan Chamani
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

7.  Sensitivity of superfolder GFP to ionic agents.

Authors:  Olesya V Stepanenko; Olga V Stepanenko; Irina M Kuznetsova; Vladislav V Verkhusha; Konstantin K Turoverov
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

8.  Peculiarities of the Super-Folder GFP Folding in a Crowded Milieu.

Authors:  Olesya V Stepanenko; Olga V Stepanenko; Irina M Kuznetsova; Vladimir N Uversky; Konstantin K Turoverov
Journal:  Int J Mol Sci       Date:  2016-10-28       Impact factor: 5.923

Review 9.  Actinous enigma or enigmatic actin: Folding, structure, and functions of the most abundant eukaryotic protein.

Authors:  Olga I Povarova; Vladimir N Uversky; Irina M Kuznetsova; Konstantin K Turoverov
Journal:  Intrinsically Disord Proteins       Date:  2014-08-15

10.  Trypsin Induced Degradation of Amyloid Fibrils.

Authors:  Olga V Stepanenko; Maksim I Sulatsky; Ekaterina V Mikhailova; Olesya V Stepanenko; Irina M Kuznetsova; Konstantin K Turoverov; Anna I Sulatskaya
Journal:  Int J Mol Sci       Date:  2021-05-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.